logo

For the Inventor, By the Inventor

Toronto, Canada

Aventis Pasteur Limited


USPTO Granted Patents = 75

% Expired Patents = 12.0



Trademarks = 2

Forward Citations = 541

Loading Chart...
Loading Chart...

84 inventors (with patents filed for the assignee):

goldMedal Michel Henri Klein (45 out of 164 patents)

silverMedal Sheena M Loosmore (17 out of 68 patents)

bronzeMedal Andrew D Murdin (14 out of 44 patents)

4.  Yan-Ping Yang (13 out of 43 patents)

5.  Pele Chong (12 out of 63 patents)

6.  Raymond P Oomen (10 out of 50 patents)

7.  Robin E Harkness (10 out of 22 patents)

8.  Pamela L Dunn (10 out of 26 patents)

9.  Benjamin Rovinski (9 out of 31 patents)

10.  Anthony Bernard Schryvers (7 out of 30 patents)

11.  Fei-Long Yao (6 out of 17 patents)

12.  Roy Persson (6 out of 17 patents)

13.  Shi-Xian Cao (5 out of 18 patents)

14.  Ken Sasaki (5 out of 6 patents)

15.  Shi Xian Cao (4 out of 11 patents)


Core Competencies:
Meningitis Vaccines
Chlamydial Vaccines
HIV-Like Particles
Immunogenic Compositions
Biodegradable Microparticles
Acellular Pertussis
Respiratory Syncytial Virus
Recombinant Proteins
Polysaccharide Conjugates
Adjuvant Compositions
Viral Vaccine Production
Transferrin Receptors

75 patents:

1. 8309100 - [object Object] (2012-11-13),
2. 7704513 - [object Object] (2010-04-27),
3. 7384768 - [object Object] (2008-06-10),
4. 7335370 - [object Object] (2008-02-26),
5. 7241449 - [object Object] (2007-07-10),
6. 7018637 - Multi-oligosaccharide glycoconjugate bacterial meningitis vaccines (2006-03-28),
7. 7015033 - Co-expression of recombination proteins (2006-03-21),
8. 7008784 - Non-infectious, non-replicating, immunogenic human immunodeficiency virus-like particles (2006-03-07),
9. 6974581 - [object Object] (2005-12-13),
10. 6933137 - Animal component free meningococcal polysaccharide fermentation and seedbank development (2005-08-23),
11. 6872814 - Chlamydia antigens and corresponding DNA fragments and uses thereof (2005-03-29),
12. 6855537 - Macrophage-infecting parasites expressing a granulocyte macrophage colony stimulated factor (2005-02-15),
13. 6849447 - Protective recombinant Haemophilus influenzae high molecular weight proteins (2005-02-01),
14. 6811783 - Immunogenic compositions for protection against chlamydial infection (2004-11-02),
15. 6808713 - Chlamydia antigens and corresponding DNA fragments and uses thereof (2004-10-26),
Company Overview
Aventis Pasteur Limited, based in Toronto, Canada, specializes in the development and manufacturing of vaccines aimed at preventing infectious diseases. The company focuses on innovative technologies in vaccine research, particularly in areas such as meningitis and chlamydial vaccines, as well as HIV-like particles and immunogenic compositions. Their expertise extends to the creation of biodegradable microparticles and acellular pertussis vaccines, contributing significantly to public health through advanced immunization solutions.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

75 Patents

#17 in Toronto

#167 in Canada

#10,007 in the World

Toronto, CA
Toronto, Canada

Aventis Pasteur Limited

Forward Citations = 541

84 inventors:

goldMedal Michel Henri Klein (45 out of 164 patents)

silverMedal Sheena M Loosmore (17 out of 68 patents)

bronzeMedal Andrew D Murdin (14 out of 44 patents)

4.  Yan-Ping Yang (13 out of 43 patents)

5.  Pele Chong (12 out of 63 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Aventis Pasteur Limited. Retrieved from https://idiyas.com/company/aventis-pasteur

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…